Diagnamed Holdings Corp. (CSE:DMED)

Diagnamed Holdings Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Net Income	-1.85	-1.4	-0.5	-1.28	-1.13	-1.95
Stock-Based Compensation	0.58	0.38	-	0.01	0.14	-
Other Operating Activities	0.51	0.34	-0.22	0.05	-	1.26
Change in Accounts Receivable	0	-	-	-0.01	-0.01	-0.03
Change in Accounts Payable	0.19	0.34	0.26	0.16	0.22	0.15
Change in Other Net Operating Assets	-0.01	0.01	0.02	-	-	-
Operating Cash Flow	-0.58	-0.34	-0.44	-1.07	-0.79	-0.57
Operating Cash Flow Growth	-	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-	0.03
Investing Cash Flow	-	-	-	-	-	0.03
Issuance of Common Stock	0.59	0.36	-	0.1	-	2.97
Other Financing Activities	0.03	-	-	-	-	-0.08
Financing Cash Flow	0.62	0.36	-	0.1	-	2.89
Net Cash Flow	0.03	0.02	-0.44	-0.96	-0.79	2.36
Levered Free Cash Flow	-0.46	-0.38	-0.36	-0.68	-0.36	-
Unlevered Free Cash Flow	-0.46	-0.38	-0.36	-0.68	-0.36	-
Change in Working Capital	0.18	0.35	0.27	0.15	0.21	0.12

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error